Antidepressant/anxiolytic and anti-nociceptive effects of novel 2-substituted 1,4-benzodiazepine-2-ones

Scientia Pharmaceutica

Volumn 78, Issue 2, 2010, Pages 155-169

  Singh, Harjit ^a   Sattayasai, Jintana ^b   Lattmann, Pornthip ^a   Boonprakob, Yodchai ^b   Lattmann, Eric ^a  

^a ASTON UNIVERSITY   (United Kingdom)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

2 Substituted 1; 4 Benzodiazepine; Analgesics; Antidepressants; Dye; In vivo studies; Oxazepam

Indexed keywords

2 1,4 BENZODIAZEPINE 2 ONE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; OXAZEPAM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DEPRESSION; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG SYNTHESIS; IN VIVO STUDY; MOUSE; NOCICEPTION; NONHUMAN;

EID: 77954646179     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1004-12     Document Type: Article

References (21)

1. Martin IL, Lattmann, E. Benzodiazepine recognition site ligands and GABAA receptors. Exp Opin Ther Patents. 1999; 9: 1347-1352. doi:10.1517/13543776.9.10.1347
2. Lattmann E, Billington DC, Poyner DR. Synthesis and evaluation of Asperlicin analogues as non-peptidal Cholecystokinin-antagonists. Drug Des Discov. 2001; 17: 219-223. PMid:11469752
3. Wilson TM, Henke BR, Momtahen, TM. 3-[2-(N-Phenylacetamide)]-1,5-benzodiazepines: Orally active, binding selective CCK-A agonists. J Med Chem. 1996; 39: 3030-3039. doi:10.1021/jm960205b
4. Showell, GA, Bourrain S, Neduvelil, JG. High affinity and potent, water soluble 5-amino-1,4-benzodiazepine CCKB/gastrin receptor antagonists. J Med Chem. 1994; 37: 719-726. doi:10.1021/jm00032a002
5. Wood MR, Homnick CF, Murphy KL. Benzodiazepines as potent and selective bradykinin B1 antagonists. J Med Chem. 2003; 46: 1803-1811. doi:10.1021/jm034020y
6. Varty GBP, Ursula C, Galen J. The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists. Neuropsychopharmacology. 2002; 27: 371-378. doi:10.1016/S0893-133X(02)00313-5
7. Sansone M, Castellano C, Pavone F. Opioid benzodizapine tifluadom and drug-induced hyperactivity in mice-lack of benzodiazepine-like effects. Pol J Pharmacol Pharm. 1985; 37: 585-561. PMid:2870483
8. Petrillo, P, Amato M, Tavani A. The interaction of the two isomers of the opioid benzodiazepine tifluadom with binding sites and their analgesic and intestinal effects in rats. Neuropeptides. 1985; 5: 403-409. doi:10.1016/0143-4179(85)90039-3
9. th May 2003; PCT/GB2004/002252, 27/05/2004
10. Roskoski R, Ritchie PA. Time-dependent inhibition of protein farnesyltransferase by a benzodiazepine peptide mimetic. Biochemistry. 2001; 40: 9329-9335. doi:10.1021/bi010290b
11. F. Hoffmann-La Roche & Co. Aktiengesellschaft, Basel/Schweiz, Swiss Patent 2.233.482.
12. Stempel A, Douvan I, Reeder E. Quinazolines and 1,4-benzodiazepines. 4,1,5-benzoxadiazocin-2-ones, a novel ring system. J Org Chem. 1967; 32: 2417-2428. doi:10.1021/jo01283a013
13. Sternbach LH, Reeder E. Quinazolines and 1,4-benzodiazepines. The rearrangement of 6-chloro-2-chloromethyl-4- phenylquinazoline 3-oxide into 2-amino derivatives of 7-chloro-5-phenyl-3H-1,4-benzodiazepine 4-oxide. J Org Chem. 1961; 26: 1111-1123. doi:10.1021/jo01063a034
14. Avadagic A, Lesac A, Majer Z. Oxidation of quinazolines and 1,4-benzodiazepines. Helv Chim Acta. 1988; 81: 1567-1572. doi:10.1002/hlca.19980810558
15. Cepanec I, Litvic M, Pogorelic I. Efficient synthesis of 3-hydroxy-1,4-benzodiazepines oxazepam and lorazepam by new acetoxylation reaction of 3-position of 1,4-benzodiazepine ring. Org Proc Res Dev. 2006; 10: 1192-1199. doi:10.1021/op068009u
16. Stempel A, Reeder E, Sternbach LH. Quinazolines and 1,4-benzodiazepines. Mechanism for ring enlargement of quinazoline 3-oxide with alkali to 1,4-benzodiazepin-2-one 4-oxides. J Org Chem. 1965; 30: 4267-4271. doi:10.1021/jo01023a063
17. Stempel A, Douvan I, Reeder E. Quinazolines and 1,4-benzodiazepines. 1,5-benzoxadiazocin-2-ones, a novel ring system. J Org Chem. 1967; 32: 2417-2422. doi:10.1021/jo01283a013
18. Kulkarni Y D, Abdi SHR, Sharma VL. Synthesis of 3-substituted-amino/arcyloxy-7-chloro-5-phenyl-1,3-dihydro-2H-1,1,4-benzodiazepin-2- ones as possible anxiolytics. J Ind Chem Soc. 1986; 425-432.
19. Offel M, Lattmann P, Singh H, Billington DC, Lattmann E. Synthesis of substituted 3-anilino-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepinones and their evaluation as cholecystokinin ligands. Arch Pharm. 2006; 339: 163-173. doi:10.1002/ardp.200500217
20. Lattmann E, Lattmann P, Sattayasai J. In vivo evaluation of substituted 3-amino- 1,4-benzodiazepines as anti-depressant-, anxiolytic- and anti-nociceptive agents. Arzneimittelforschung. 2009; 59. 61-71 PMid:19338136
21. Lattmann E, Sattayasai J, Offel M. Anti-depressant and anti-nociceptive effects of 1,4-Benzodiazepine-2-ones based Cholecystokinin (CCK2) antagonists. Drug Discov Ther. 2007; 1: 45-56.